ReviewCardiovascular diabetology2026

Combination of GLP-1 receptor agonists and SGLT2 inhibitors in cardiometabolic disease: synergistic, additive, or non-additive effects? A narrative review.

Eirini Stamouli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.